Innovative
Therapeutics for
Better Health

Because Life
Shouldn't Have to
Wait for Migraines

Our Lead Product Candidate

STS101

Dihydroergotamine (DHE) Nasal Powder

Learn More

Clinical Trials

SUMMIT™ Trial

Currently Recruiting

Learn More

Clinical Trials

ASCEND™ Trial

Ongoing

Learn More

Press Releases

Nov 09, 2021

Satsuma Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Read More

Oct 28, 2021

Satsuma Pharmaceuticals to Present at Upcoming Healthcare Conferences

Read More